This user account status is Approved
Women’s HIV risk is often unrecognized and overlooked, resulting in less awareness about HIV prevention options, especially surrounding HIV prevention medications. Awareness can be impacted by stigma, systemic barriers, and personal circumstances. This resource is intended for cis and Trans women to increase their awareness of the HIV prevention medications that are available to foster…
Fatal and non-fatal drug toxicity ratios are at a crisis point among those who are pregnant and newly parenting in Ontario. This trend is happening amongst reports that overdose and drug toxicity is decreasing; overdose prevention and harm reduction services are being scaled back, and provincial policies are being implemented that increase the criminalization and…
A report on how Bill 6: The Safer Municipalities Act and Bill 10:The Protect Ontario Through Safer Streets and Stronger Communities Act will impact cis women and gender-diverse people.
A report on how the closure of SCS will have a dire impact on women and gender-diverse people. This resource seeks to bring a gendered lens to our understanding of the impacts of the Community Care and Recovery Act by outlining 5 key considerations and laying the groundwork for strategies to address these impacts.
Learn more about PIP - a prescription for Post-Exposure Prophylaxis (PEP), which is a 28-day course of HIV medications you can take to significantly reduce the risk of HIV infection after a potential exposure to HIV.
WHAI’s resource on what undetectable = untransmittable (U=U) means for women. This resource is intended to be used to support community conversations about women and HIV, and the U=U messaging.